Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PYCR
3026
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $3.19M | ﹤0.01% |
+90,563
| New | +$2.97M |
|
3027
RBB Bancorp
RBB
$454M
| $3.17M | ﹤0.01% |
125,852
-4,374
| -3% | -$107K |
|
|
EGIO
3028
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.17M | ﹤0.01% |
33,289
-130
| -0.4% | -$13.7K |
|
3029
Tenaris
TS
$28.7B
| $3.17M | ﹤0.01% |
149,937
-82,392
| -35% | -$1.67M |
|
3030
Lyell Immunopharma
LYEL
$316M
| $3.17M | ﹤0.01% |
+10,692
| New | +$3.2M |
|
3031
Dr. Reddy's Laboratories
RDY
$10B
| $3.14M | ﹤0.01% |
240,940
-2,038,880
| -89% | -$27.2M |
|
|
NEUE
3032
DELISTED
NeueHealth
NEUE
| $3.14M | ﹤0.01% |
+4,806
| New | +$4.23M |
|
3033
UNIFI
UFI
$120M
| $3.14M | ﹤0.01% |
143,045
-7,483
| -5% | -$170K |
|
|
FLXN
3034
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.13M | ﹤0.01% |
512,747
-3,413
| -0.7% | -$21.3K |
|
3035
Kiniksa Pharmaceuticals
KNSA
$5.66B
| $3.13M | ﹤0.01% |
274,558
-11,640
| -4% | -$152K |
|
|
DRRX
3036
DELISTED
DURECT Corp
DRRX
| $3.12M | ﹤0.01% |
243,949
+6,669
| +3% | +$90.5K |
|
3037
Sociedad Química y Minera de Chile
SQM
$19B
| $3.12M | ﹤0.01% |
58,098
-428,542
| -88% | -$21.9M |
|
3038
Aviat Networks
AVNW
$266M
| $3.11M | ﹤0.01% |
94,697
-1,930
| -2% | -$66.7K |
|
|
USX
3039
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $3.11M | ﹤0.01% |
360,098
+8,042
| +2% | +$69.8K |
|
3040
Cytosorbents Corp
CTSO
$23.3M
| $3.11M | ﹤0.01% |
382,481
-23,130
| -6% | -$188K |
|
3041
Fidelity MSCI Health Care Index ETF
FHLC
$3.27B
| $3.11M | ﹤0.01% |
48,676
+380
| +0.8% | +$25.1K |
|
|
IAS
3042
DELISTED
Integral Ad Science
IAS
| $3.1M | ﹤0.01% |
150,049
+121,855
| +432% | +$2.4M |
|
3043
Amalgamated Financial
AMAL
$1.48B
| $3.09M | ﹤0.01% |
195,489
-41,906
| -18% | -$641K |
|
3044
Cytek Biosciences
CTKB
$558M
| $3.08M | ﹤0.01% |
+143,859
| New | +$3.38M |
|
3045
Aligos Therapeutics
ALGS
$28.4M
| $3.08M | ﹤0.01% |
7,932
+811
| +11% | +$321K |
|
3046
Acacia Research
ACTG
$434M
| $3.07M | ﹤0.01% |
452,260
-16,222
| -3% | -$99.3K |
|
3047
Hippo Holdings
HIPO
$860M
| $3.07M | ﹤0.01% |
+26,239
| New | +$4.6M |
|
|
SIEN
3048
DELISTED
Sientra, Inc.
SIEN
| $3.05M | ﹤0.01% |
53,230
-2,332
| -4% | -$159K |
|
3049
TherapeuticsMD
TXMD
$23.8M
| $3.04M | ﹤0.01% |
82,040
+4,121
| +5% | +$183K |
|
3050
UWM Holdings
UWMC
$645M
| $3.03M | ﹤0.01% |
435,870
+199,425
| +84% | +$1.48M |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.